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Résumé en
anglais
The finding of monoclonal gammopathy of undetermined significance (MGUS) is
not infrequent during an evaluation for osteoporosis or a fracture. In most cases,
the diagnosis is MGUS, whose prevalence increases with age. Although the impact
of MGUS on bone mineral density, bone remodeling, and the fracture risk remains
unclear, this asymptomatic hematological disorder may constitute a risk factor for
osteoporosis. Furthermore, each year, 1% of patients with MGUS progress to
multiple myeloma, a disease whose pathophysiology and association with bone loss
and pathological fractures are increasingly well understood. Osteoporotic
fractures, although probably common in myeloma patients, are less likely to be
recognized. Here, we discuss the pathophysiology of myeloma and MGUS and their
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